Pharmaceutical package
Latest Janssen Biotech, Inc. Patents:
- DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO SINGLE HORMONAL INSULIN POSITIVE CELLS
- Prostate neoantigens and their uses
- Anti-TNF antibodies, compositions, and methods for the treatment of active Ankylosing Spondylitis
- Fibronectin type III domain based scaffold compositions, methods and uses
- Anti-CD38 antibodies for treatment of acute myeloid leukemia
The broken line portion in the drawings illustrates portions of the pharmaceutical package that form no part of the claimed design.
Claims
The ornamental design for a pharmaceutical package, as shown and described.
D249617 | September 26, 1978 | Bozicnik |
7441655 | October 28, 2008 | Hoftman |
D698644 | February 4, 2014 | Teopas |
D740650 | October 13, 2015 | Waldron |
D817172 | May 8, 2018 | Jones |
D895145 | September 1, 2020 | Smith |
D906815 | January 5, 2021 | Yu |
D918032 | May 4, 2021 | Smith |
D934069 | October 26, 2021 | Cook |
20180085515 | March 29, 2018 | Mide |
20190092547 | March 28, 2019 | Sadowski |
1386753 | May 2010 | JP |
D103295 | March 2005 | TW |
D103296 | March 2005 | TW |
Type: Grant
Filed: Sep 18, 2020
Date of Patent: Apr 19, 2022
Assignee: Janssen Biotech, Inc. (Horsham, PA)
Inventors: Cedric Gysel (Zurich/Canton Zurich), Michael Cannamela (Atlantic Highlands, NJ), Roland Schultz (Stein), Peter Braun (Hallau)
Primary Examiner: Lauren R Calve
Application Number: 29/751,225